Paul Hudson, Sanofi CEO (Eric Piermont/AFP via Getty Images)
Sanofi is in the market for M&A, thanks to ‘strong’ balance sheet
Sanofi is likely to increase its M&A this year since it has more cash in its pockets, as the French pharma also monitors China as …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
